BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Livingston-Rosanoff D, Foley DP, Leverson G, Wilke LG. Impact of Pre-Transplant Malignancy on Outcomes After Kidney Transplantation: United Network for Organ Sharing Database Analysis. J Am Coll Surg 2019;229:568-79. [PMID: 31666186 DOI: 10.1016/j.jamcollsurg.2019.06.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Hao X, Lai W, Xia X, Xu J, Wu Y, Lv C, Meng Q, Lv K, Huang S, Luo Z, Dong J, Yuan Q. Skin cancer outcomes and risk factors in renal transplant recipients: Analysis of organ procurement and transplantation network data from 2000 to 2021. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1017498] [Reference Citation Analysis]
2 Hao X, Lai W, Xia X, Xu J, Wu Y, Lv C, Lv K, Huang S, Luo Z, Meng Q, Yuan Q, Dong J. Transplant or dialysis: What’s the better choice for RCC-induced ESRD patients? A 20-year analysis of OPTN/UNOS data. Front Oncol 2022;12:955771. [DOI: 10.3389/fonc.2022.955771] [Reference Citation Analysis]
3 Piana A, Andras I, Diana P, Verri P, Gallioli A, Campi R, Prudhomme T, Hevia V, Boissier R, Breda A, Territo A. Small renal masses in kidney transplantation: overview of clinical impact and management in donors and recipients. Asian Journal of Urology 2022. [DOI: 10.1016/j.ajur.2022.06.001] [Reference Citation Analysis]
4 Sekowski V, Jackson K, Halloran K, Varughese R, Nagendran J, Weinkauf J, Lien D, Hirji A. Pre-transplant malignancy is associated with increased risk of de novo malignancy post-lung transplantation. Respiratory Medicine 2022;197:106855. [DOI: 10.1016/j.rmed.2022.106855] [Reference Citation Analysis]
5 Salcedo M, Vinaixa C, Javle M, Trapero-Marugán M, Bustamante J, Line PD. Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference. Transplantation 2022;106:e3-e11. [PMID: 34905758 DOI: 10.1097/TP.0000000000003997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Schreiber B, Abdelrahim M, Abudayyeh A, Murakami N. Emerging Concepts in Managing Malignancy in Kidney Transplant Patients. Seminars in Nephrology 2022;42:63-75. [DOI: 10.1016/j.semnephrol.2022.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Engels EA, Haber G, Hart A, Lynch CF, Li J, Pawlish KS, Qiao B, Yu KJ, Pfeiffer RM. Predicted Cure and Survival Among Transplant Recipients With a Previous Cancer Diagnosis. J Clin Oncol 2021;39:4039-48. [PMID: 34678077 DOI: 10.1200/JCO.21.01195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Regmi S, Rattanavich R, Villicana R. Kidney and pancreas transplant candidacy. Curr Opin Organ Transplant 2021;26:62-8. [PMID: 33332923 DOI: 10.1097/MOT.0000000000000843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Delman AM, Turner KM, Ammann AM, Tang A, Steward D, Holm TM. Avoiding delays in time to renal transplantation: Pretransplant thyroid malignancy does not affect patient or graft survival after renal transplantation. Surgery 2021:S0039-6060(21)00455-4. [PMID: 34303544 DOI: 10.1016/j.surg.2021.03.064] [Reference Citation Analysis]
10 Becker F, Mehdorn AS, Getsopulos V, Schütte-Nütgen K, Reuter S, Suwelack B, Pascher A, Brockmann JG, Bahde R. Tumor Recurrence and Graft Survival in Renal Transplant Recipients with a History of Pretransplant Malignancy: A Matched Pair Analysis. J Clin Med 2021;10:2349. [PMID: 34071904 DOI: 10.3390/jcm10112349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Engels EA, Haber G, Hart A, Lynch CF, Li J, Pawlish KS, Qiao B, Yu KJ, Pfeiffer RM. Solid Organ Transplantation and Survival among Individuals with a History of Cancer. Cancer Epidemiol Biomarkers Prev 2021;30:1312-9. [PMID: 33926864 DOI: 10.1158/1055-9965.EPI-21-0044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Williams GJ, Webster AC, Thompson JF. Organ transplantation and outcomes in patients with a past history of melanoma: A systematic review and meta-analysis. Clin Transplant 2021;35:e14287. [PMID: 33720403 DOI: 10.1111/ctr.14287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Al-Adra D, Al-Qaoud T, Fowler K, Wong G. De Novo Malignancies after Kidney Transplantation. Clin J Am Soc Nephrol 2021:CJN. [PMID: 33782034 DOI: 10.2215/CJN.14570920] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
14 Al-Adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'Cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al-Qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. Am J Transplant 2021;21:460-74. [PMID: 32969590 DOI: 10.1111/ajt.16318] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
15 Al‐adra DP, Hammel L, Roberts J, Woodle ES, Levine D, Mandelbrot D, Verna E, Locke J, D'cunha J, Farr M, Sawinski D, Agarwal PK, Plichta J, Pruthi S, Farr D, Carvajal R, Walker J, Zwald F, Habermann T, Gertz M, Bierman P, Dizon DS, Langstraat C, Al‐qaoud T, Eggener S, Richgels JP, Chang GJ, Geltzeiler C, Sapisochin G, Ricciardi R, Krupnick AS, Kennedy C, Mohindra N, Foley DP, Watt KD. Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement. Am J Transplant 2021;21:475-83. [DOI: 10.1111/ajt.16324] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
16 Bojic M, Watschinger C, Reiter T, Watschinger B. Waiting times in renal transplant candidates with a history of malignancy: time for a change? Curr Opin Nephrol Hypertens 2020;29:623-9. [PMID: 32941190 DOI: 10.1097/MNH.0000000000000652] [Reference Citation Analysis]
17 Shrestha BM. Issues and Outcomes after Renal Transplantation in Recipients with Pre-Transplant Malignancy. J Am Coll Surg 2020;230:356. [PMID: 32093900 DOI: 10.1016/j.jamcollsurg.2020.01.001] [Reference Citation Analysis]